The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Elotuzumab with lenalidomide and low-dose dexamethasone in patients with relapsed multiple myeloma: A randomized phase II study.
P. G. G. Richardson
Consultant or Advisory Role - Bristol-Myers Squibb; Celgene; Johnson & Johnson; Millennium; Novartis
P. Moreau
No relevant relationships to disclose
A. J. Jakubowiak
Consultant or Advisory Role - Bristol-Myers Squibb (U)
Honoraria - Bristol-Myers Squibb; Celgene
T. Facon
Consultant or Advisory Role - Bristol-Myers Squibb
S. Jagannath
Consultant or Advisory Role - Celgene; Merck; Millennium
R. Vij
Consultant or Advisory Role - Bristol-Myers Squibb; Celgene
Honoraria - Bristol-Myers Squibb; Celgene
D. E. Reece
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen-Ortho; Merck; Novartis; Otsuka
Research Funding - Bristol-Myers Squibb; Celgene; Janssen-Ortho; Johnson & Johnson; Merck; Novartis
D. White
No relevant relationships to disclose
M. Raab
No relevant relationships to disclose
L. Benboubker
No relevant relationships to disclose
J. Rossi
Consultant or Advisory Role - Celgene; Sanofi
Honoraria - Celgene; Sanofi
C. Tsao
Employment or Leadership Position - Abbott Laboratories
T. Parli
Employment or Leadership Position - Abbott Biotherapeutics
Stock Ownership - Abbott Laboratories
D. M. Berman
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
A. K. Singhal
Employment or Leadership Position - Abbott Laboratories
S. Lonial
Consultant or Advisory Role - Bristol-Myers Squibb; Celgene; Merck; Millennium; Novartis; Onyx
Research Funding - Bristol-Myers Squibb; Celgene; Merck; Millennium; Novartis; Onyx